Head-to-head · WeighScore
boostAGErx vs TeleHealth Med
The verdict
Too close to call — both grade 66.1/100 (C).
boostAGErx and TeleHealth Med land on the same WeighScore, so neither clears the other on our six graded dimensions. boostAGErx sits one line higher on the board (#201 vs #209) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | boostAGErx | TeleHealth Med |
|---|---|---|
| WeighScore | 66.1/100 | 66.1/100 |
| Grade | C | C |
| Scorecard rank | #201 | #209 |
| Semaglutide | $95/mo (billed every 28 days, compounded) | $147/mo (starting dose, compounded) |
| Tirzepatide | $145/mo (billed every 28 days, compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #201 · C
Strengths
- Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
- Free shipping and clinical evaluation included
- Membership fee refunded in full if you're not approved
- Also offers peptide therapy such as sermorelin
- 100% online with licensed providers — no clinic visit
Where it loses points
- Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
- The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
- Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
- Shipped compounded medication is non-refundable
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #209 · C
Strengths
- Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
- Publishes the FDA compounded-medication disclaimer
- 503A pharmacy designation stated in the FAQ
- Honest disclosure that testimonials are compensated and results aren't independently verified
- Both injectable and sublingual forms offered
Where it loses points
- Specific 503A pharmacy partner not named
- LegitScript ID number not shown in text — only a verification link
- Full states-served list not disclosed
- Named medical director not disclosed
- Dose tiers beyond the $147/mo starting price not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.